Performance analysis of Inovio Pharmaceuticals (INO)
Annual Return
Over the past 3 years, INO has had an average annual return of -45.32%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, INO has had an average annual return of -58.80%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, INO has had an average annual return of -37.88%, underperforming the benchmark SPY, which returned +15.45% annual.
Since Nov 1, 1999, INO has had an average annual return of -20.98%, underperforming the benchmark SPY, which returned +8.56% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -34.48% | -6.45% | -69.61% | -67.31% | -68.74% | -43.62% | +168.18% | -17.50% | -3.15% | -40.49% | +3.27% | -26.80% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| -20.86% | +480% | +16.96% | -62.83% | +0.88% | +119.23% | -43.48% | -72.04% | +44.93% | -42.39% | -21.20% | +362.96% |
| 2002 | 2001 | 2000 | 1999 | ||||||||
| -57.81% | -31.73% | -71.15% | +4% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.90% | +11.11% | -3.33% | -34.48% | +15.79% | -13.64% | -34.48% | ||||||
| 2025 | +12.90% | -5.71% | -18.18% | +18.52% | +3.13% | +3.03% | -29.41% | +66.67% | -2.50% | -0% | -12.82% | -14.71% | -6.45% |
| 2024 | -11.76% | +64.44% | +56.08% | -17.32% | -11.52% | -20.12% | +31.85% | -32.58% | -20.00% | -8.33% | -18.18% | -56.94% | -69.61% |
| 2023 | +6.41% | -24.10% | -34.92% | -6.10% | -22.08% | -25.83% | +19.10% | -15.09% | -13.33% | -6.41% | +8.22% | +29.11% | -67.31% |
| 2022 | -17.03% | -21.74% | +10.80% | -23.96% | -31.50% | -7.49% | +14.45% | +15.66% | -24.67% | +25.22% | -5.56% | -23.53% | -68.74% |
| 2021 | +44.07% | -12.94% | -16.40% | -26.62% | +10.87% | +22.78% | -9.39% | +2.86% | -17.13% | -0.28% | +1.40% | -31.08% | -43.62% |
| 2020 | +37.27% | -5.52% | +73.83% | +61.69% | +22.61% | +82.71% | -27.87% | -38.32% | -3.25% | -15.09% | +24.06% | -27.58% | +168.18% |
| 2019 | +25.25% | -26.95% | +1.91% | +0.80% | -36.44% | +23.01% | -6.12% | -21.74% | -5.09% | +3.90% | +18.31% | +30.95% | -17.50% |
| 2018 | +10.41% | -10.09% | +14.88% | -6.79% | +8.43% | -17.65% | +2.30% | +31.17% | +5.70% | -11.33% | +8.52% | -25.23% | -3.15% |
| 2017 | -4.90% | +6.82% | -6.10% | -4.98% | +20.03% | +3.84% | -29.08% | +6.83% | +6.73% | -8.04% | -21.27% | -10.02% | -40.49% |
Drawdown analysis of Inovio Pharmaceuticals (INO)
The maximum drawdown for the INO was -99.95%, occurring on Apr 7, 2026. This drawdown has not yet recovered.
The current INO drawdown is -99.95%.
Since Nov 1, 1999 INO has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 2 times
- 20% or more: 3 times
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.95% | Mar 3, 2000 | 6561 | Apr 7, 2026 | Ongoing | Ongoing | Ongoing |
| -38.67% | Feb 17, 2000 | 4 | Feb 24, 2000 | 6 | Mar 3, 2000 | 10 |
| -22.71% | Jan 11, 2000 | 5 | Jan 19, 2000 | 11 | Feb 3, 2000 | 16 |
| -14.29% | Dec 21, 1999 | 4 | Dec 28, 1999 | 10 | Jan 11, 2000 | 14 |
| -12.00% | Nov 1, 1999 | 4 | Nov 5, 1999 | 31 | Dec 21, 1999 | 35 |
| -10.12% | Feb 8, 2000 | 2 | Feb 10, 2000 | 2 | Feb 14, 2000 | 4 |
| -4.36% | Feb 3, 2000 | 1 | Feb 4, 2000 | 2 | Feb 8, 2000 | 3 |